Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...

Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who ...

The 0.25mg, 0.5mg and 1mg dosage of Wegovy will cost ₹17,345 for a month. A higher dose form of 1.75mg will cost ₹24,280 a month, while 2.4mg dose will be for ₹26,050. The drug follows a four-week ...

The jab has been rolled out in a bid to tackle climbing obesity levels and support individuals returning to work ...

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

Separately, Novo Nordisk presented early data for its oral amycretin program. In Phase I and Ib/IIa trials, amycretin ...

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough ...

Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...